Research Oriented Pharma Company Investment opportunity
About Business
Formulation Development, Project Management, Out-Licensing, Analytical Development, Fee for Services
Clientele type
ELC Group, Zydus Cadila,Esteve, Slayback pharma, STI Pharma, Gyma, Medtronic etc.
Premises
Office in USA also
Asking Price Includes
Stake offered as per valuation
Reason
Increasing R&D Capacity & Capability.
Developing more Out licensing & Proprietary products.
More Details
85 years + Combined Exp. of Heads
21 Research Scientists. All are Phd
Founders have stellar record in leading MNC pharma cos. & have deep technical & commercial understanding.
Ready for the next phase of growth via introducing Proprietary products.
Keywords
Business Tags
₹10 to ₹200 Cr
Complete Investment Banking Solution in 120 Days
Seamless Fundraising/M&A transactions
Start your growth journey with our 25+ Years of Experienced Professional Team.
Contact IBGrid Team